oncogene

The stem cell leukemia( SCL) gene is a new oncogene related with leukemogenesis.

Neutrophil gelatinase-associated lipocalin(NGAL) is a novel member of the lipocalin family and may be a new human oncogene, but the regulation mechanism of NGAL was not clear in the cancer.

Novel oncogene with kinase-domain (NOK) can activate multiple mitogenic signaling pathways including the janus kinases (JAK) and signal transducer and activator of transcription proteins (STAT).

Oncogene mutations can lead to uncontrolled cell growth.

Research is being conducted on oncogene inhibitors.

The oncogene expression is associated with tumor formation.

Scientists are studying the role of oncogenes in cancer development.

Targeting oncogenes has become a key strategy in cancer therapy.

The activation of oncogenes can promote cell proliferation.

Mutations in oncogenes can drive tumorigenesis.

Oncogene research has advanced our understanding of cancer.

Inhibiting oncogene signaling pathways is a promising approach in cancer treatment.

The identification of oncogene mutations is crucial for personalized medicine.